Search
Abbott Laboratories
ABTAdd to Watchlist
102.980USD
+0.370+0.36%
Close 09-21 16:00（ET）
178.16BMarket Cap
28.57P/E TTM
After-hours 19:00 (ET)102.980USD+0.015+0.01%
After-hours 19:00 (ET)Abbott Laboratories (ABT) Stock Price Target & Forecast
Analyst Rating
Based on 29 analysts giving stock ratings to Abbott Laboratories in the past month.
Buy
11 Strong Buy
12 Buy
6 Hold
0 Sell
0 Strong Sell
Target Price
120.971USD+17.89%
ABT Analyst Recommendation Trends
In the current month, ABT has received 12 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. ABT average Analyst price target in the last month is 120.971.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
11
11
10
9
9
9
9
9
12
12
12
12
13
14
13
13
6
6
9
9
9
8
9
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
29
31
30
31
31
31
31
ABT Analyst Rating for Peer Comparison
Updated: Sep 21, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
11
13
6
0
0
30
Medtronic PLC
MDT
9
10
11
0
0
30
Dexcom Inc
DXCM
13
13
4
0
0
30
Zimmer Biomet Holdings Inc
ZBH
2
6
21
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Insulet Corp
PODD
7
8
12
0
0
27
Guardant Health Inc
GH
12
13
2
0
0
27
Repligen Corp
RGEN
5
14
3
0
0
22
Tandem Diabetes Care Inc
TNDM
4
8
10
0
0
22
Alcon AG
ALC
6
8
2
1
0
17
Financial Forecasting
Based on analysts' estimates, ABT EPS is projected to reach 1.420 in FY2026Q3, following reported EPS of 0.533 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.50
1.14
1.28
1.42
1.64
Actual
1.02
0.62
0.53
--
--
Surprise
-31.75%
-45.96%
-58.32%
--
--
FAQs
What is Abbott Laboratories's expected revenue for the next quarter?
Abbott Laboratories's expected revenue is 12.99B.
What is Abbott Laboratories's price target?
Analysts forecast that Abbott Laboratories's price target is USD 120.97, with the highest forecast at USD 136.00 and the lowest forecast at USD 103.00.
How have Abbott LaboratoriesABT's recent earnings per share performed?
The market expectation was USD 0.53, while Abbott LaboratoriesABT's earnings per share (EPS) for the previous quarter was USD 0.62. EPS for the next quarter is expected at USD 1.42.
What is the analyst rating for Abbott Laboratories?
Based on the ratings of Abbott Laboratories's stock from 29 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.